Development of a Canadian Bronchiectasis and NTM Database
1 other identifier
observational
2,000
1 country
1
Brief Summary
The investigators aim to develop a comprehensive patient registry of patients with non-CF bronchiectasis and/or Nontuberculosis Mycobacteria (NTM)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 28, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2050
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2050
November 22, 2023
June 1, 2023
27 years
June 28, 2023
November 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Patient Recruitment and Data analysis for NTM and Bronchiectasis
Descriptive analysis of demographics and clinical parameters and epidemiological evaluation of No. of hospitalizations, No. of exacerbations.
December 2050
Study Arms (2)
Non-CF Bronchiectasis Patients with or without NTM
Patients over the age of 18 with non-CF Bronchiectasis with or without Nontuberculosis Mycobacteria (NTM).
Nontuberculosis Mycobacteria (NTM)
Patients over the age of 18 with Nontuberculosis Mycobacteria (NTM)
Eligibility Criteria
Patients over the age of 18 with non-CF Bronchiectasis and/or Nontuberculosis Mycobacteria (NTM).
You may qualify if:
- Over the age of 18
- Non-CF Bronchiectasis
- Nontuberculosis Mycobacteria (NTM)
You may not qualify if:
- Under the age of 18
- CF bronchiectasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Insmed Incorporatedcollaborator
- Trudell Medical Internationalcollaborator
Study Sites (1)
University of Calgary
Calgary, Alberta, T2N4N1, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 20 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2023
First Posted
November 22, 2023
Study Start
January 1, 2023
Primary Completion (Estimated)
January 1, 2050
Study Completion (Estimated)
January 1, 2050
Last Updated
November 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share